(Q24240398)

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

A randomized-controlled trial of prophylactic hydrocortisone supplementation for the prevention of hypotension in extremely low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

A single very early dexamethasone dose improves respiratory and cardiovascular adaptation in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

A double-blind, randomized, controlled study of a "stress dose" of hydrocortisone for rescue treatment of refractory hypotension in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Trial of early neonatal hydrocortisone: two-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Maternal nutrition and birth weight. These factors are related

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

The effects of early postnatal dexamethasone therapy on pulmonary outcome in premature infants with respiratory distress syndrome: a two-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Early (4-7 days of age) dexamethasone therapy for prevention of chronic lung disease in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Early dexamethasone treatment in preterm infants treated with surfactant: a double blind controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Meta-analysis of dexamethasone therapy started in the first 15 days of life for prevention of chronic lung disease in premature infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Postnatal corticosteroids in preterm infants: systematic review of effects on mortality and motor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Mortality, severe respiratory distress syndrome, and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant Curosurf.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Growth retardation after dexamethasone administration: assessment by knemometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

The influence of betamethasone and dexamethasone on motor development in young rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Inflammatory mediators and bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Clinical trials of postnatal corticosteroids: inhaled and systemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Randomized placebo-controlled trial of a 42-Day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants: a 3-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Early postnatal dexamethasone treatment and increased incidence of cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Postnatal dexamethasone in preterm infants is potentially lifesaving, but follow up studies are urgently needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

The therapeutic use of glucocorticoid hormones in the perinatal period: Potential neurological hazards

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Early dexamethasone therapy in preterm infants: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Antenatal Glucocorticoid Treatment and Cystic Periventricular Leukomalacia in Very Premature Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

Early postnatal dexamethasone therapy may lessen lung inflammation in premature infants with respiratory distress syndrome on mechanical ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

7 January 2021

Prevention of chronic lung disease in preterm infants by early postnatal dexamethasone therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

7 January 2021

Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk preterm infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

7 January 2021

Effect of dexamethasone therapy on the neonatal ductus arteriosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

7 January 2021

Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

7 January 2021

Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

7 January 2021

Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

7 January 2021

The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

7 January 2021

Single-dose dexamethasone treatment of hypotension in preterm infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

7 January 2021

Using cerebral palsy data in the evaluation of neonatal intensive care: a warning

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

7 January 2021

Influence of early postnatal dexamethasone therapy on ventilator dependency in surfactant-substituted preterm infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

7 January 2021

More trials on early treatment with corticosteroids are needed

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

7 January 2021

Vascular endothelial growth factor in pulmonary lavage fluid from premature infants: effects of age and postnatal dexamethasone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

7 January 2021

Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. A randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

7 January 2021

Early low-dose hydrocortisone in very preterm infants: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

7 January 2021

Influence of postnatally administered glucocorticoids on rat lung growth

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

7 January 2021

Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

7 January 2021

Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

7 January 2021

A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

7 January 2021

Early dexamethasone therapy and blood cell count in preterm infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

7 January 2021

Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

7 January 2021

Early dexamethasone-attempting to prevent chronic lung disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB3

7 January 2021

10.1002/14651858.CD001146.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

20091516

1 reference

Consolidated OpenCitations Corpus – April 2017